Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 8, 2017
Discovery of Streptococcus pneumoniae serogroup 35 variants in Australian patientsM Staples, R M A Graham, V Hicks, et al.Epidemiology and Infection|May 22, 2023
Genomic analysis of an outbreak of toxin gene bearing Corynebacterium diphtheriae in Northern Queensland, Australia reveals high level of genetic similarityRikki M A Graham, Irani U Rathnayake, Sumeet Sandhu, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1993
Vascular rejection in heart transplant recipientsL W Miller, A Wesp, S H Jennison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumorsC A Johnson, D Kilpatrick, R von Roemeling, et al.Infection and Immunity|January 31, 2007
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse modelAbiodun D Ogunniyi, Kim S LeMessurier, Rikki M A Graham, et al.Epidemiology and Infection|March 27, 2014
Molecular characterization of an Australian serotype 1 Streptococcus pneumoniae outbreakM Staples, R M A Graham, A V Jennison, et al.Biochemical Pharmacology|August 4, 1992
Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drugJ Cummings, M A Graham, B M Hoey, et al.Cancer Research|May 15, 1992
Phase I and pharmacokinetic study of rhizoxinD Bissett, M A Graham, A Setanoians, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancerN Kemeny, W Tong, M Gonen, et al.Pageof 11